Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways
- 1 January 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 210, 232-241
- https://doi.org/10.1016/j.jep.2017.08.029
Abstract
No abstract availableKeywords
Funding Information
- Key Research and Development Project (2016ZDJQ0108)
- National Key Technology R&D Program (2017ZX09301022)
This publication has 33 references indexed in Scilit:
- Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammationJournal of Hepatology, 2012
- Therapeutic targets in liver fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β SignalingOnline Journal of Public Health Informatics, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligationJournal of Hepatology, 1993
- Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.JCI Insight, 1992
- Colchicine in the Treatment of Cirrhosis of the LiverThe New England Journal of Medicine, 1988